Cancer Immunology, Immunotherapy

Published by: Springer  

Groups

  1. Adult Leukemia (5)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  3. Center for Hematologic Malignancies (5)
  4. Center for Molecular Imaging and Biotechnology (5)
  5. Department of Medicine (5)
  6. GSK Faculty (5)
  7. Hematologic Malignancies Research (5)
  8. Hematologic Malignancies, Division of (5)
  9. Molecular Pharmacology and Chemistry Program Faculty (5)
  10. Sloan Kettering Institute Faculty (5)
Search Within
Publishers
  1. Springer (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer Immunology, Immunotherapy – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Immunology and Immunotherapy 978-3-642-14136-2 Springer Verlag
    Cancer Immunology Immunotherapy 0340-7004 Springer
    Cancer Immunology Immunotherapy 0340-7004 Unknown
    Cancer Immunology Immunotherapy 0340-7004 Springer
    Cancer Immunology Immunotherapy 0340-7004 Springer
    Cancer Immunology Immunotherapy 0340-7004 Springer Verlag
    Cancer Immunology Immunotherapy 03407004 Springer Verlag
    Cancer Immunology Immunotherapy 03407004 Unknown
    Cancer Immunology Immunotherapy 0340-7004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 03407004 2022, The Author(s), Under Exclusive Licence To Springer Verlag Gmbh Germany, Part of Springer Nature
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 03407004 2018, Springer Verlag Gmbh Germany, Part of Springer Nature
    Cancer Immunology, Immunotherapy 03407004 2019, The Author(s)
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 03407004 The Author(s)
    Cancer Immunology, Immunotherapy 03407004 2022, The Author(s)
    Cancer Immunology, Immunotherapy 03407004 2023, The Author(s)
    Cancer Immunology, Immunotherapy 03407004 2023, The Author(s), Under Exclusive Licence To Springer Verlag Gmbh Germany, Part of Springer Nature
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag Berlin Heidelberg
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag Berlin Heidelberg
    Cancer Immunology, Immunotherapy 03407004 The Author(s) 2024
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 03407004 Unknown
    Cancer Immunology, Immunotherapy 03407004 Us Government